Treatment with AGR-H19-Rgof lncRNA mimics improved glucose metabolism, alleviated insulin resistance, and reduced serum triglyceride concentrations under HFD challenge (Fig. 7n and Additional file 4: Fig. S9h-k). The gene discussed is H19; the disease is Insulin resistance.